Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI TrialValery T. Miller, Sally A. Shumaker, John C. LaRosa et al.|JAMA|1995Cited by 605
Longitudinal Patterns and Predictors of Alcohol Consumption in the United StatesAlison Moore, Arun S. Karlamangla, Robert Gould et al.|American Journal of Public Health|2005Cited by 308
Disparities in Reproductive Aging and Midlife Health between Black and White women: The Study of Women’s Health Across the Nation (SWAN)Sioḃán D. Harlow, Tené T. Lewis, Sherri‐Ann M. Burnett‐Bowie et al.|Women s Midlife Health|2022Cited by 97
Antimullerian Hormone and Impending Menopause in Late Reproductive Age: The Study of Women’s Health Across the NationJoel S. Finkelstein, Nanette Santoro, Patrick M. Sluss et al.|The Journal of Clinical Endocrinology & Metabolism|2020Cited by 93
Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women’s Health Across the NationNanette Santoro, Bill L. Lasley, Sybil L. Crawford et al.|The Journal of Clinical Endocrinology & Metabolism|2017Cited by 72